MedTrace Logo

Association of Multiple CardiOvascular Risk Factors and Erectile Function Across Europe

NCT00468637 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 1200

Last updated 2009-02-16

No results posted yet for this study

Summary

The purpose of the study is to evaluate the influence of cardiovascular risk factors, heart failure and cardiovascular drug therapy on erectile function in cardiovascular high-risk patients.

Conditions

Sponsors & Collaborators

  • Pfizer

    collaborator INDUSTRY

  • University Hospital, Saarland

    lead OTHER

Principal Investigators

  • Michael Böhm, MD · Department of Cardiology, University Hospital of the Saarland

  • Magnus Baumhäkel, MD · Department of Cardiology, University Hospital of the Saarland

Eligibility

Min Age
18 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-05-31
Completion
2011-09-30

Countries

  • Germany
  • Italy
  • Poland

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00468637 on ClinicalTrials.gov